These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8166964)

  • 1. [Cystic fibrosis: molecular aspects and therapeutic prospects].
    Mazza P
    Boll Chim Farm; 1994 Jan; 133(1):35-8. PubMed ID: 8166964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cystic fibrosis: current therapy. Inhalation therapy with recombinant DNAse].
    Rutishauser M
    Schweiz Med Wochenschr Suppl; 2000; 122():47S-48S. PubMed ID: 12536474
    [No Abstract]   [Full Text] [Related]  

  • 3. Which DNAse in cystic fibrosis?
    Morice AH
    Lancet; 1993 Sep; 342(8871):624-5. PubMed ID: 8102760
    [No Abstract]   [Full Text] [Related]  

  • 4. DNase in cystic fibrosis: the challenge of assessing response and maximising benefit.
    Innes JA
    Thorax; 1998 Dec; 53(12):1003-4. PubMed ID: 10195066
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
    Zach MS
    Thorax; 1996 Jul; 51(7):750-5. PubMed ID: 8882085
    [No Abstract]   [Full Text] [Related]  

  • 6. [New therapeutic modalities for pulmonary disease in cystic fibrosis].
    Virgilis D; Augarten A; Szeinberg A; Yahav Y
    Harefuah; 1995 Dec; 129(12):569-72. PubMed ID: 8682360
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclease therapeutics in the clinic.
    Edgington SM
    Biotechnology (N Y); 1993 May; 11(5):580-2. PubMed ID: 7763605
    [No Abstract]   [Full Text] [Related]  

  • 8. Question 2: should hypertonic saline be used in patients with cystic fibrosis who respond unsatisfactorily to recombinant deoxyribonuclease?
    Badurdeen S; Ross-Russell R
    Arch Dis Child; 2010 Jul; 95(7):562-4. PubMed ID: 20551202
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human DNase in cystic fibrosis.
    Milla CE
    Lancet; 1999 Jul; 354(9176):428. PubMed ID: 10437902
    [No Abstract]   [Full Text] [Related]  

  • 10. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1994 Feb; 271(7):494. PubMed ID: 8301750
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo-controlled n-of-1 trials in cystic fibrosis.
    Mitchell I; Doig CJ
    Eur Respir J; 1999 Oct; 14(4):993; author reply 994. PubMed ID: 10573256
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy/cost ratio of new therapy. What is the physician's fiduciary responsibility?
    Pingleton SK
    Chest; 1994 Feb; 105(2):329-30. PubMed ID: 8306717
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current therapeutic agents: dornase alfa].
    Baran D; Sternon J
    Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract]   [Full Text] [Related]  

  • 15. Placebo-controlled n-of-1 trials in cystic fibrosis.
    Webb S; Tansey P; Brown H; Jackson A; Bilton D
    Eur Respir J; 1999 Oct; 14(4):993; author reply 994. PubMed ID: 10573255
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cystic fibrosis: time for a new paradigm?
    Bush A
    Chest; 2009 Nov; 136(5):1197-1199. PubMed ID: 19892669
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis.
    Amaral MD; Kunzelmann K
    Trends Pharmacol Sci; 2007 Jul; 28(7):334-41. PubMed ID: 17573123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun; 63(6):705. PubMed ID: 9687230
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.